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Abstract: Muco-ciliary transport in the human airway is a crucial defense 
mechanism for removing inhaled pathogens. Optical coherence tomography 
(OCT) is well-suited to monitor functional dynamics of cilia and mucus on 
the airway epithelium. Here we demonstrate several OCT-based methods 
upon an actively transporting in vitro bronchial epithelial model and ex vivo 
mouse trachea. We show quantitative flow imaging of optically turbid 
mucus, semi-quantitative analysis of the ciliary beat frequency, and 
functional imaging of the periciliary layer. These may translate to clinical 
methods for endoscopic monitoring of muco-ciliary transport in diseases 
such as cystic fibrosis and chronic obstructive pulmonary disease (COPD). 
© 2012 Optical Society of America 
OCIS codes: (170.4500) Optical coherence tomography; (110.4153) Motion estimation and 
optical flow; (170.2655) Functional monitoring and imaging; (170.3880) Medical and biological 
imaging; (110.6150) Speckle imaging; (110.0113) Imaging through turbid media. 
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1. Introduction 
During respiration, humans inhale thousands of airborne pathogens per hour that are deposited 
onto the surface of the airways. To combat this constant influx of pathogens, the respiratory 
tract is lined with airway surface liquid consisting of a mucus layer and a periciliary layer 
(PCL) [1]. Within the PCL, cilia on the epithelium beat in a coordinated fashion to clear 
mucus from the airways. In diseases such as cystic fibrosis (CF) [2] and chronic obstructive 
pulmonary disease (COPD) [3], thickened mucus results in defective mucociliary clearance 
(MCC), leading to chronic lung infection and impaired pulmonary function. As such, MCC 
from the lung is a critical biomarker of respiratory health [4]. Currently, in vivo measurements 
of MCC are typically performed by having a patient inhale technetium particles, with 
clearance measured by a gamma camera [5]. This method provides the overall clearance rates 
across gross sections of the lung. However, this method cannot capture fine heterogeneities in 
MCC, or functional metrics such as the thickness of the mucus layer and the ciliary beat 
frequency (CBF). OCT presents the unique opportunity to accurately measure MCC, the depth 
of the mucus layer, and ciliary activity in the lung, providing clinicians with a more reliable 
measure of MCC. In this paper we describe several methods for quantifying airway functional 
metrics, and demonstrate them in actively transporting in vitro models and ex vivo tissues. 
Since early studies using OCT to image the respiratory tract [6], the applications of OCT 
for in vivo human imaging of the airways have been growing. Some notable studies include a 
44 subject study of airway wall thickness in COPD [7], a 148 subject study of pre-invasive 
bronchial lesions [8], a 43 subject study of airway compliance in a variety of pulmonary 
diseases [9], the development of a 2.2 mm diameter probe for real-time imaging in the 
bronchus [10], and development of an OCT probe guided by flexible bronchoscope to detect 
suspicious masses in the lung [11]. OCT imaging of MCC in the human airway represents a 
particular challenge because of the large dynamic range of time scales involved, from slow 
mucus flow rates to rapid ciliary beating. Recent work has demonstrated how a variety of 
cellular processes can be characterized by unique speckle fluctuation spectroscopic signatures 
[12,13]. Here we characterize, for the first time, the speckle fluctuation spectra of human 
airways, and show how selecting different passbands allows us to preferentially contrast 
mucus flow or ciliary activity within airway epithelium. 
To quantify mucus transport rates, a method for tracking cilia-driven flow using particle 
tracking velocimetry (PTV) in OCT was recently demonstrated [14], where it was emphasized 
that the ability for OCT to depth-resolve flow is crucial for understanding the physiology of 
cilia-driven flow. However, we find that PTV is not always possible in airway mucus that is 
turbid and produces OCT images that are non-sparse. Importantly, people with CF, COPD, 
and asthma suffer from thick mucus and mucus plugging which impede pulmonary function 
[15–17]. In CF in particular, the ability to monitor improvements in MCC during therapeutic 
intervention would be beneficial [18]. To address this, here we demonstrate a cross-
correlation method for quantifying flow of thick and optically turbid mucus. 
Another imaging challenge is the small size of airway cilia (~7 μm in length), which 
would require the use of novel sub- and single-micrometer resolution OCT systems, such as 
those previously reported [19,20], in order to spatially resolve them. However, as we will 
show below, functional information on the cilia beat frequency (CBF) can still be obtained 
with a more moderate axial resolution of ~3 µm, which is sufficient to resolve the PCL. 
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Overall, this paper describes OCT-based methods for quantifying mucus flow, CBF, and 
imaging ciliary activity, which are demonstrated on both in vitro and ex vivo airway 
epithelium models. 
2. Methods 
2.1. In vitro and ex vivo airway models 
Our in vitro model for airway epithelium consists of primary, normal human bronchial 
epithelial (hBE) cells that are cultured on a porous membrane (Fig. 1). This model 
recapitulates several important features of the human airway epithelium [21]. As cells develop 
over several weeks, they become polarized and form a contiguous epithelium, acting to 
exclude liquid media from their apical surface so that they reside at an air-liquid interface. 
Also, the hBE cells secrete mucus, which accumulates over time in culture. Importantly, hBE 
cells grow cilia at the apical surface, which beat in a coordinated fashion and actively 
transport mucus. Because these cells are cultured in a circular horizontal culture dish, unlike 
in vivo, they tend to transport accumulated mucus in a rotational, hurricane-like, pattern. 
In this study, hBE cells were cultured on 0.4 mm pore size Millicells (Millipore, Billerica, 
MA) coated with collagen and maintained in air-liquid interface media (UNC Tissue Core) as 
described previously [21]. Cultures were examined after 6 weeks, when the hBE cells were 
confluent, had fully developed cilia, and were able to transport mucus. Hurricane cultures 
were allowed to accumulate mucus over a 48 hr period prior to imaging. Mucus hurricane  
 
Fig. 1. Representative OCT images of airway models. (a) B-mode (x-z) OCT of ex vivo mouse 
trachea. (b) M-mode (time-z) OCT of ex vivo mouse trachea associated with panel (a). The 
apparent location of the periciliary layer (PCL) is indicated by regions of rapid speckle 
fluctuation. (c) Diagram of geometry used for opening and subsequently imaging the mouse 
trachea. (d) B-mode OCT of in vitro hBE model with thick mucus at an air-liquid interface. 
The porous membrane is highly optically scattering, while the hBE cells are observed as a more 
weakly scattering layer immediately above the membrane. The thick mucus layer above the 
hBE cells is also optically scattering due to cellular detritus. (e) M-mode OCT of the in vitro 
model associated with panel (d). The apparent PCL is located immediately above the hBE cell 
layer, as expected. (f) Representative histology section of an in vitro hBE culture showing the 
detailed structure of the epithelium; this culture exhibited a thinner mucus layer than the one 
depicted in (d) and (e). 
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imaging was performed both with OCT (described below), and, for validation, on an Olympus 
IX-71 Inverted Microscope operating in standard brightfield mode, with both 4 × and 10 × 
objectives. Microscopy image sequences were collected using a JAI CM-030GE grey-scale 
camera at 90 fps and sampled over 1215 × 914 μm into 656 × 494 pixels in x × y, respectively. 
For histology, cells were fixed with osmium tetraoxide in perfluorocarbon, Epon-embedded, 
and stained with Richardson’s. 
For ex vivo tissues, tracheas from 3 mice (C57BL/6) were obtained from freshly sacrificed 
mice and kept in saline before OCT imaging. All mice were handled according to approved 
protocols at the Institutional Animal Care and Use Committee (IACUC) at the University of 
North Carolina at Chapel Hill. Two tracheas were sliced axially and opened for imaging 
perpendicular to the luminal surface (as shown in Fig. 1(c)), while the third trachea was kept 
intact for imaging of both luminal and basal surfaces (OCT beam nearly parallel to these 
surfaces). 
Both in vitro and ex vivo models were imaged before and after isoflurane treatment, which 
is known to slow ciliary activity [22]. This was performed by incubating the cells or tissues 
with ~20% isoflurane for 5 minutes, rinsing with saline, and immediately imaging. 
2.2. OCT system hardware and data acquisition 
The spectral domain OCT system used in this study has been described in detail previously 
[23]. Briefly, a Ti:sapphire laser (KMLabs, Inc.) provided light centered at 810 nm with a 3 
dB bandwidth of 125 nm, corresponding to a coherence length of 2 µm in tissue. The light 
was directed into a free space Michelson interferometer with 10 mW of optical power incident 
upon the sample and imaging optics providing a transverse resolution of 12 µm and a confocal 
parameter of 0.28 mm. The output of the interferometer was directed into a spectrometer to 
sample the spectral interferogram into 2048 pixels of a line scan camera (Dalsa Piranha 2). 
OCT images were obtained by Fourier transformation of the spectral interferogram after 
processing steps including reference spectrum subtraction [24] and digital dispersion 
compensation [25,26]. The signal-to-noise ratio of this system was typically >95 dB. 
B-mode OCT was performed for mucus flow studies and speckle fluctuation contrast of 
the PCL. Images were collected in x-z (transverse × axial) over (1−3) × 1.5 mm into 
(150−1000) × 1024 pixels, respectively. The camera linerate was set to either 5 or 10 kHz for 
collection of 100 frames in a time series, at adjustable frame rates spanning from 0.82 fps to 
40 fps. M-mode OCT was also performed for cilia beat rate analysis with the same parameters 
as in B-mode except the x dimension was not scanned, and only 10 sequential frames were 
recorded. 
2.3. Mucus flow imaging by cross-correlation 
Imaging airway mucus flow is challenging for several reasons. Mucus flow is predominantly 
transverse to the OCT beam axis in typical imaging geometries, but transverse flows are not 
possible to measure with traditional Doppler OCT techniques [27,28]. New Doppler methods 
for quantifying both transverse and axial flows have been developed for hemodynamic 
imaging [29], but are affected by the distribution of sizes and anisotropy of the scattering 
particles within the flow volume, which may be difficult to control in airway mucus. 
Furthermore, mucus flow velocities are typically 2 orders of magnitude smaller than blood 
flow, with flow velocities typically ranging from 10−60 µm/s. This longer time scale makes it 
more difficult to maintain phase stability needed for Doppler OCT while particles traverse the 
imaging beam. On the other hand, mucus flow can be effectively frozen by imaging at 
moderate frame rates in the 10s of Hz, suggesting the use of PTV, such as recently reported 
for studying cilia-driven flow [14]. However, in that study, the fluids were optically clear and 
tracer particles were added. We find that mucus that has accumulated in hBE cultures contains 
a large amount of cellular detritus, making it optically turbid with developed speckles in the 
OCT image, and thus does not fit the requirement of sparse imaging needed for PTV. 
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Importantly, people suffering from many respiratory diseases have characteristically thick 
mucus. 
Given these challenges, we employed a normalized, 2D cross-correlation for speckle 
tracking. These types of methods were originally developed for motion tracking in ultrasonic 
imaging [30,31], and have been previously employed in OCT for compensation of motion 
artifacts [32] and for tracking elastic deformation [33]. Given a point (x0, z0) around which we 
wish to compute the velocity, we first obtained a normalized cross-correlation between two 
images in the time series, I1 and I2, separated by Δt12 in time, as follows: 
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where X and Z are the window sizes and the correlation ρ(x′,z′) is computed over 
( )max maxx x x′−∆ < < ∆ and ( )max maxz z z′−∆ < < ∆ , where Δxmax and Δzmax are the maximum 
displacement sizes. We then found the values of x′ and z′ at which ρ(x′,z′) was at a maximum, 
and determined the velocity components vx = (x0-x′)/Δt12 and vz = (z0-z′)/Δt12. vx and vz were 
then obtained at all desired values of (x0, z0) to generate a velocity map. 
Balancing the added time of computation against increasing the available dynamic range 
in velocity, we chose window sizes of X = 30 and Z = 10 pixels, maximum displacement sizes 
of Δxmax = 8 and Δzmax = 5 pixels, and sampled x0 and z0 on a 5 × 5 pixel mesh within the 
image. We omitted any (x0, z0) points where the root-mean-squared (RMS) pixel intensities 
summed over the window (the denominator in Eq. (1)) was less than a threshold value. 
Because mucus flow is approximately in a steady-state in the in vitro models, we reduced 
noise by obtaining the median values of vx and vz over time intervals Δtij across the entire time 
series (every 5−10 frames, or 0.5−1s intervals, over 100 frames, or 10s). It was important to 
adjust the time interval so that the maximum displacement would be close to but less than 
Δxmax or Δzmax in order to maximize the dynamic range. We also rotated the reference frame to 
align with that of the epithelial cell layer, which was slightly tilted with respect to the incident 
beam. The resulting vx and vz maps were 2 × 2 mean filtered and visualized in a hue-
saturation-value (HSV) color map by assigning hue to velocity and saturation and value to 
RMS pixel intensity. 
We applied the same method to x-y microscopy images collected for flow validation, with 
settings Δtij = 0.55s, X = 20 and Y = 20 pixels, Δxmax = 5 and Δymax = 13 pixels, and otherwise 
the same settings as for OCT. Test image sets were generated from both OCT and microscopy 
images, where each frame was stepped a known displacement over a simulated time series. 
Velocities extracted by cross-correlation were confirmed to match the simulated velocities. 
2.4. Ciliary beat rate quantification by Fourier analysis 
With some exceptions [19,20], most OCT systems currently do not offer the resolution needed 
to spatially resolve individual airway cilia. However, our OCT system axial resolution of ~3 
µm is, in most cases, sufficient to resolve the PCL within the airway surface liquid [34], while 
our transverse spot size of ~12 µm covers ~12 hBE cells and ~2000 individual cilia. Despite 
this limitation, we expect that the speckle fluctuation arising from the movement of an 
ensemble of sub-resolution cilia can be related to the ciliary beat frequency (CBF), for the 
following reasons. It is known that neighboring cilia tend to coordinate into metachronal 
patterns, i.e., sharing the same CBF with a constant phase difference [35]. The ciliary beat 
motion has a complicated shape (Fig. 2(a)) but is periodic with a frequency of typically 5 Hz 
at room temperature and 10 Hz at 37°C for healthy airway epithelium [36]. The speckle 
pattern in OCT arises from interferences between sub-resolution light scatterers, such as cilia. 
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During the cilia beat cycle we would expect these interferences to change in a highly 
complicated way (Fig. 2(b)), however, fundamentally this pattern should be time-periodic. As 
such, we would expect the Fourier spectrum of speckle fluctuations from cilia to have peaks at 
the CBF and its harmonics. In practice, we find that such peaks cannot be observed and are 
blurred together over a bandwidth several times that of the CBF. This is possibly due to 
overlying mucus motion changing the light beam refraction at the air-liquid interface, mucus 
scattering within the PCL, or creep in the system causing phase instability on this 100−200 ms 
time scale. 
 
Fig. 2. (a) Diagram of cilia beat pattern during the effective stroke (red) and the recovery stroke 
(green) [37]. (b) Cartoon illustrating dynamic light scattering from cilia during OCT imaging. 
Hundreds of cilia are simultaneously illuminated by the OCT beam. The coordinated beat 
pattern of a few cilia are illustrated, showing how the relative axial spacing between cilia (Δz) 
rapidly changes during one beat cycle. The OCT signal fluctuates when Δz changes by λ/2≈400 
nm. This is why we expect to observe many fluctuations during a single beat cycle, giving rise 
to an apparent fluctuation rate many times greater than the CBF. 
Despite the lack of a clear CBF spectral peak, we realized that, in the assumption that the 
beat motion pattern remains the same when the CBF increases or decreases, (i.e., the OCT 
amplitude is an arbitrary, time-harmonic function that does not change pattern when the cilia 
speed up or slow down), one would expect the Fourier spectrum to linearly expand or 
contract, respectively. Mathematically one might write this as 
 ( ){ } ( )2C DC
C
I t S Sωω δ ω σ
ω
 
= + + 
 
   (2) 
where I is the arbitrary, time-harmonic speckle amplitude arising from cilia with a 
characteristic CBF of ωC, S is the power spectral density for ω > 0, SDC is the DC offset (δ is 
the Kronecker delta function), σ  accounts for additive white noise (such as shot noise), and 
negative frequencies are omitted for convenience. For noisy data, one robust method for 
determining the relative scale of the spectrum S is to compute its median ωm, that is, the 
frequency that evenly divides the area under the power spectrum curve. According to (2), we 
see that ωm is linearly proportional to ωC, providing a relative measure of the CBF. 
This method was implemented by obtaining the power spectral density S at each depth 
within an M-mode OCT scan and spatially averaging spectra over 3 pixels. The white noise, 
σ , was estimated as the average over the 1.5-2.5 kHz band (2.5 kHz being the Nyquist 
frequency); the exact choice of the lower limit of this band between 1 and 2 kHz had little 
effect on our results (<5%). After subtraction of the DC term and the white noise, the median 
ωm was computed. Visual inspection of each image was used to determine an 8 pixel PCL 
region, and the maximum value of ωm within this region was recorded for each of 10 frames 
collected at each of 2-3 independent positions for each sample (in vitro and ex vivo) both 
before and after isoflurane treatment. For the purposes of display only, ωm was thresholded to 
omit rows below a minimum light scattering intensity. 
(C) 2012 OSA 1 September 2012 / Vol. 3,  No. 9 / BIOMEDICAL OPTICS EXPRESS  1984
#168949 - $15.00 USD Received 21 May 2012; revised 6 Jul 2012; accepted 6 Jul 2012; published 1 Aug 2012
2.5. Speckle fluctuation contrast for PCL imaging 
In order to extend the 1D method above to 2D OCT imaging of the PCL, we note that high 
frame rates (ωm >100 Hz) would be needed to directly capture the speckle fluctuations arising 
from ciliary activity. However, taking cues from OCT angiography where blood flow is often 
too rapid to directly capture [38], we can semi-quantitatively image ciliary activity by 
computing the standard deviation (or variance) of the speckle fluctuations. In our experiments, 
we find that phase is not generally stable, and we instead compute the variance of the OCT 
amplitude, a method which was recently shown to give comparable results to phase variance 
methods for blood flow imaging [39]. 
Interestingly, airway epithelium dynamics occur over a wide range of time scales, from 
slow mucus transport to fast ciliary beating, and so it is important to define the frequency 
band in which variance calculations are performed. We note that, using a discrete version of 
Parseval’s theorem, the variance of a time series x that is sampled at intervals of Δt over a 
total time T = (N-1)Δt is directly proportional to the power spectral density of x, |X|2, 
integrated over a frequency band bounded by the spectral resolution, Δf = 1/T, and the Nyquist 
frequency, fNyq = 1/(2Δt), as follows: 
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Using this relation, one can tailor the time scale of interest to match the imaging target by the 
choice of Δt and T. This is also a computationally efficient method in comparison to direct 
Fourier analysis, which is important when collecting 2- and 3-D imaging data. 
We implemented this method by analyzing B-mode OCT time series collected at variable 
frame rates from 0.82−40 fps. The Nyquist frequency could be further reduced from that 
dictated by the sampling rate by skipping frames in the series, and Δf was adjusted by 
choosing how many images of the series to include in the analysis. The standard deviation σ 
was computed for each pixel across the time series, and was normalized by the shot noise 
estimated as the square root of the mean value in each pixel. Mean filtering of this signal was 
performed in 4 × 4 pixel windows. Using this method, we processed images of the in vitro 
hurricane hBE model and ex vivo mouse trachea into 3 frequency bands spanning nearly 3 
decades. 
3. Results and discussion 
3.1. Mucus flow imaging 
We studied an in vitro hBE culture exhibiting mucociliary transport of thick (~100-250 µm) 
mucus. Using light microscopy, we found that the transverse mucus motion was in a circular, 
hurricane-like pattern, consistent with previous observations in these types of cultures [21]. B-
mode OCT imaging and quantitative flow analysis was performed in cross-sectional slices 
moving across the center of the hurricane. A representative data set obtained near the 
periphery of the hurricane is shown in Fig. 3. The real-time video suggests mucus motion 
predominantly parallel to the epithelial surface to the right (positive x direction). Also, one 
can observe a more rapid speckle decorrelation rate near both edges of the image. The 
computed flow maps corroborate these observations, where the velocity is largely 
homogeneous in the positive x direction, except near the edges where high variance is 
observed due to the rapid decorrelation. This decorrelation is likely due to the component of 
mucus motion through the image plane (vy), which is expected to be greater near the edges 
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than in the center of the hurricane. This effect dictates a tradeoff in the choice of frame rate, as 
sufficiently high frame rate is needed to capture speckles in regions with a high vy component, 
while sufficiently low frame rate is needed to allow for speckles to move a number of pixels 
in the x-z plane order to minimize digitization noise in the velocity measurement. In practice, 
we find the optimum frame rates to lie between 1−2 fps. It may be possible, in future work, to 
quantify vy based upon this loss of correlation using a previously described method [40]; in 
this case, careful calibration would be needed to account for the beam divergence over the 
large imaging depth range needed to assess thick mucus. 
 
Fig. 3. Depth-resolved mucus flow imaging of an in vitro hBE culture with hurricane-like 
mucus motion. (a) Cartoon illustrating the OCT image plane off-center from the hurricane. (b) 
Microscopy (x-y) of 1 µm fluorescent beads trapped in mucus in an hBE culture exhibiting 
hurricane motion, 2 second exposure. (c) Video comprised of a B-mode (x-z) OCT time series 
at 2 × real time (Media 1). (d) Corresponding transverse velocity map, vx, computed using 
cross-correlation. (e) Axial velocity map, vz. All scale bars are 200 µm. 
We note that OCT can provide new information about the axial component of velocity, vz, 
and the depth dependence of vx during MCC. Here we find that vx appears to be constant in z 
except near the air-liquid interface; the surface effect may be an artifact of more rapid 
decorrelation at the interface due to changes in surface height. The homogeneous depth profile 
of vx is consistent with the view that mucus travels as a slab. In comparison, vz is not 
significantly different from zero. It will be interesting in future work to learn whether mucus 
flow in living, breathing organisms is depth-dependent due to shear forces from air flow, 
which may lead to better models of muco-ciliary transport. 
In order to validate flow quantification by OCT, we compared the depth-averaged vx to the 
components of flow vx′ and vy′ obtained by light microscopy; orientation was not maintained 
between the experiments so the axes may be different. The results are summarized in Fig. 4. 
For OCT, the depth-averaged vx was computed within the mucus layer for B-mode images 
across a 2.7 mm × 3.0 mm (x-y) area of the hurricane. A clear transition from negatively-
directed flow to positively-directed flow is seen as the B-mode slice is moved across the 
center of the hurricane, with values that ranged from −34 to + 35 µm/s. Microscopy was 
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performed in the same culture immediately after OCT imaging within a 0.9 mm × 1.2 mm 
window, resulting in a similar transition in flow direction across the center of the hurricane, 
with values ranging from −41 to + 29 µm/s. As a point of reference, human mucus velocity 
has previously been measured to be 40 μm/s in the main bronchi and 92 μm/s in the trachea in 
healthy subjects [41]. 
 
Fig. 4. Transverse mucus flow imaging of an in vitro hBE culture with hurricane-like motion. 
(a) Cartoon illustrating the OCT imaging scan pattern across the hurricane. (b) The depth-
averaged velocity vx obtained by OCT, mapped across the x-y surface of the culture, shows the 
reversal of flow direction across the eye of the hurricane. (c) Maximum intensity projection of 
a time series of microscopy images of the same hurricane. (d) and (e) Velocity components vx′ 
and vy′ obtained by microscopy, respectively. The same velocity and spatial scales are used in 
(b), (d), and (e). 
While the OCT data was obtained over a larger area than the microscopy data, it is 
relevant to compare the velocity gradient across the hurricane. We find that the velocity 
gradient by microscopy was significantly asymmetric, with values of 25 and 61 μm s−1/mm 
for ∂vx′/∂y′ and ∂vy′/∂x′, respectively. At the same time, we noted an elongated physical 
appearance to the hurricane. In comparison, the velocity gradient ∂vx/∂y by OCT was 23 μm 
s−1/mm, which is consistent with the slow axis observed in microscopy. Previous measures of 
flow in these hurricane models was reported in [42], where a similar range of velocities and a 
velocity gradient of ~77 μm s−1/mm was observed. Future improvements to our OCT system 
may provide 3D imaging at sufficient frame rates to enable quantification of all mucus 
velocity components simultaneously. Alternately, rapid scanning of slightly offset B-mode 
planes could provide the vy component locally, as demonstrated previously in phantoms [43]. 
3.2. Ciliary beat rate 
Another important parameter is the ciliary beat frequency (CBF), because it regulates the rate 
of mucus clearance [44]. In order to modulate CBF in a controlled study, we used a high dose 
of a gaseous anesthetic, which is expected to slow the cilia [22,45,46]. As an independent 
measure, we first used light microscopy to monitor the effect of 20% isoflurane added to 
separate hBE cultures. We found that CBF dropped from an initial value of 5.2 ± 0.5 Hz to a 
value indistinguishable from zero in less than 5 minutes (n = 3). After extensive washing of 
the isoflurane, the CBF recovered to 3.7 ± 0.9 Hz, suggesting that hBE cells remain viable 
after isoflurane treatment. For study with OCT, we evaluated hBE cultures that had been 
cleared of mucus, and healthy ex vivo mouse trachea with only a thin, transparent mucus 
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layer, in order to directly measure the speckle fluctuations from the cilia. To validate that the 
median frequency, ωm, of the speckle power spectrum is correlated with ciliary activity, we 
performed M-mode OCT on these models before and after 20% isoflurane. 
Representative OCT data is displayed in Fig. 5. Visual inspection of the M-mode images 
reveals rapid speckle fluctuation within the topmost light scattering layer, which is where the 
PCL is expected to be located. The associated Fourier spectra versus depth reveal a strong, 
broadband response within this layer in comparison to the cells below. It is important to note 
that we also expect some motion of the basal body, where the cilia are attached, and as such, 
the apparent layer of high fluctuation may include some of this region beneath the actual PCL. 
Induced motion of mucus immediately above the PCL may also exhibit rapid speckle 
fluctuations. As such, our following discussion on the “apparent” PCL should be understood 
to include these layers, in addition to the true PCL. 
Computation of ωm versus depth reveals a peak within the PCL of ~100−120 Hz, which is 
many times larger than the actual CBF, as expected based on the discussion in 2.4 above. 
Interestingly, the full width at half maximum of this peak is approximately 7.4 ± 1.5 μm in  
 
Fig. 5. Representative beat frequency analyses for in vitro and ex vivo models cleared of 
mucus. Results are shown before and after isoflurane treatment to slow cilia beating, from M-
mode images (left images) to corresponding Fourier spectra (middle images) to median 
frequency ωm (right plots). Yellow arrows indicate the depth position of the apparent PCL 
before isoflurane treatment; after treatment the activity is dramatically slowed within the PCL. 
 
Fig. 6. Peak median frequency ωm within the PCL for ex vivo and in vivo airways before and 
after isoflurane treatment. Mean and standard deviation were evaluated over 10 images each at 
2-3 independent locations per sample. 
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depth, consistent with the known PCL thickness [34]. As expected, we found that ωm 
diminished significantly after the application of isoflurane, to a value of ~10−40 Hz for both 
ex vivo and in vitro models, suggesting that ωm scales proportionally with ciliary activity. The 
statistical results of the ωm measurements are summarized in Fig. 6. Importantly, while our 
OCT system axial resolution (3 μm) is sufficient to resolve the PCL as a whole, we can detect 
changes in the ciliary activity without spatially resolving individual cilia. 
3.3. PCL imaging using speckle fluctuation contrast 
The results above provide a basis for producing images that selectively contrast ciliary 
activity, enabling identification of the PCL. The standard deviation contrast method described 
in 2.5 was applied first to clean hBE cultures (with no mucus), as shown in Fig. 7. In some 
places, hBE cells have grown in multiple layers, and ciliary activity on the borders of each  
 
Fig. 7. Dynamic OCT imaging of in vitro hBE model with clear mucus using speckle 
fluctuation contrast in the 0.1−1 Hz band. High standard deviation at the borders of the hBE 
cells indicates ciliary activity. Lower left scale bars are 100µm. 
 
Fig. 8. Dynamic OCT imaging of an in vitro hBE model at varying time scales spanning 3 
decades. (a) Video at 10 × real time (Media 2). (b) Standard deviation image in the 0.02−0.2 
Hz band. On these long time scales mucus transport is rapid, and high variance is seen 
throughout the mucus. (c) Video at 1 × real time (Media 3). (d) Standard deviation image in the 
0.4−5 Hz band. At these intermediate time scales we observe particle tracks from scatterers 
within the mucus. (e) Video at 0.2 × real time (Media 4). (f) Standard deviation image in the 
3.3−17 Hz band. At these short time scales mucus transport appears frozen, and ciliary activity 
within the PCL becomes more evident, as indicated by the white arrow. 
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cell can be observed as regions of high speckle fluctuation. Next, dynamic imaging of hBE 
cultures with thick, turbid mucus was performed (Fig. 8). In this case, we observe high 
speckle fluctuation from mucus in frequency bands up to several Hz, including particle tracks 
observed particularly in the middle, 0.4-5 Hz band (Fig. 8(d)). In some sense, the optimum 
frame rate for mucus flow imaging (section 3.1) is within this frequency band, as it allows for 
speckle tracking within the mucus by cross-correlation. At the highest frequencies, however, 
mucus transport appears frozen, as shown in Media 4, and the ciliary activity becomes more 
prominent. Because PCL speckle fluctuation rates exceed 100 Hz for healthy epithelium (as 
shown in 3.2), we might expect even higher frame rates to provide even greater contrast 
between mucus and PCL. 
We also performed dynamic imaging of ex vivo mouse trachea. To verify that the speckle 
fluctuation is specific to ciliated cell surfaces, and not an artifact of a cell-liquid interface, we 
first imaged a tracheal tube that was on-end (Fig. 9), where the outer tracheal surface is not 
expected to be ciliated, and the inner surface is. As expected, broad regions of high speckle 
fluctuation are observed only on the inner tube surfaces, corresponding to ciliary activity. 
Next, we imaged the along the inner tracheal surface of a tube that had been cut open axially 
(Fig. 9(e)), where we observed that the ciliary activity is patchy, consistent with microscopy 
observations of patchy ciliation. In Fig. 10, we show how imaging of the tracheal surface 
varies with the choice of speckle fluctuation frequency band. Because the mucus was 
transparent, very little interference was observed, and excellent visualization of the PCL was 
provided at all 3 time scales, ranging from 0.02Hz – 20Hz. Associated videos illustrate the 
ciliary activity within different these time scales. 
 
Fig. 9. Dynamic OCT of ex vivo trachea using speckle fluctuation contrast in the 0.1−1 Hz 
band. (a) Image in plane A where the luminal surface is the rightmost vertical surface. (b) 
Image in plane B with luminal surfaces in the center. (c) Cartoon diagram of imaging 
geometry. In both (a) and (b), luminal (mucosal; ciliated) tissue surfaces have high standard 
deviation, in comparison to serosal (non-ciliated) tissue surfaces. (d) Scanning electron 
microscopy of mouse trachea showing characteristic patchiness of ciliation. (e) Image of mouse 
trachea luminal side up (according to diagram of Fig. 1(c)), showing patchy regions of rapid 
fluctuation corresponding to ciliary activity. Panels (a), (b), and (e) have the same scale. 
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Fig. 10. Dynamic OCT imaging of cut open ex vivo mouse trachea (imaging geometry of Fig. 
1(c)) at varying time scales spanning 3 decades. (a) Video at 10 × real time (Media 5). (b) 
Standard deviation image in the 0.02−0.2 Hz band. (c) Video at 1 × real time (Media 6). (d) 
Standard deviation image in the 0.2−2.5 Hz band. (e) Video at 0.2 × real time (Media 7). (f) 
Standard deviation image in the 2−20 Hz band. Because this healthy mouse lacked a thick 
mucus layer, the ciliary activity is highly contrasted at all time scales. 
4. Conclusion 
In summary, we described several methods for studying MCC in an in vitro human airway 
model and ex vivo mouse tracheas, including direct measurements of mucus flow using cross-
correlation, indirect measurements of cilia beat frequency through a proportional parameter 
given by the median frequency of the power spectrum, and qualitative imaging of the PCL 
using variance-based contrast. We also found that ciliary activity could still be visualized 
underneath a thick and turbid mucus layer by choice of a sufficiently high frequency band for 
variance contrast (>3.3 Hz). 
In addition, we measured the apparent thickness of the PCL by Fourier analysis of speckle 
fluctuations, and found that it was well-matched to the known thickness of PCL in healthy 
epithelium [34]. While future work is needed to determine whether OCT can monitor changes 
in PCL thickness, this ability would be clinically useful as PCL depletion is indicated in the 
pathogenesis of cystic fibrosis. These methods constitute a toolkit for understanding MCC in 
the human respiratory system, and can potentially provide new data about mucus thickness, 
depth-resolved flow, and ciliary activity, even in airways with thick mucus. 
The ability to translate these methods to clinical imaging depends upon several factors. 
Patient motion and respiration will invariably cause motion artifacts on moderate (~1 Hz) time 
scales that may be alleviated by motion tracking methods already used in retinal imaging [32]. 
For diseases where access to lower airways is desired, the development of catheters with 
sufficiently small diameter is technically challenging, although several groups have already 
made progress in this area [7,8,10,11]. In terms of resolution, in our experiments, the cilia 
were not spatially resolved, which relaxes requirements on beam focusing needed in 
endoscopic systems. Fundamentally, the ability to depth-resolve MCC provides new insight in 
respiratory diseases, and may lead to better methods for treatment monitoring. 
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